Published Research Articles

Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics conjugation approach for drugdelivery applications

Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics conjugation approach for drugdelivery applications Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics conjugation approach for drugdelivery applications Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics conjugation approach for drugdelivery applications Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics […]

Stabilization of cationic liposomes using hyaluronic acid-modified goldnanoparticles by post-microfluidics conjugation approach for drugdelivery applications Read Post »

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates 🔬 Introduction In the race to develop effective vaccines against COVID-19, Iranian researchers have designed an innovative mRNA-based vaccine candidate known as COReNAPCIN®. Using a lipid nanoparticle (LNP) delivery system, this vaccine aims to safely express the full-length SARS-CoV-2 spike (S) protein

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates Read Post »

Liposome/AZIF-8 Janus nanoplatforms: Promising nanocarriers forimproving chemotherapeutic outcomes in breast cancer treatment

🔬 Introduction Researchers at Mashhad University of Medical Sciences have developed an innovative dual-delivery nanoplatform designed to enhance the effectiveness of chemotherapy in breast cancer. This novel Janus nanoparticle, combining AZIF-8 and liposomes, offers targeted, simultaneous delivery of both hydrophilic and hydrophobic drugs. 🧪What Makes This Nanoparticle Special? 🧫 Key Findings (In Vitro & In

Liposome/AZIF-8 Janus nanoplatforms: Promising nanocarriers forimproving chemotherapeutic outcomes in breast cancer treatment Read Post »

Scroll to Top